This study successfully established a PTX-resistant breast cancer cell model, discovered the abnormal expression of multiple ABC transporters in it, and verified the necessity of co-inhibiting these ABC transporters for reversing MDR. The gene discussed is ABCG2; the disease is breast cancer.